Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-21-021742
Filing Date
2021-06-21
Accepted
2021-06-21 17:00:45
Documents
32
Period of Report
2021-08-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A nc10024793x1_pre14a.htm PRE 14A 950221
2 nc10024793x1_img001.jpg GRAPHIC 26539
3 nc10024793x1_img002.jpg GRAPHIC 31199
4 nc10024793x1_img003.jpg GRAPHIC 2766
5 nc10024793x1_img004.jpg GRAPHIC 15903
6 nc10024793x1_img005.jpg GRAPHIC 17753
7 nc10024793x1_img006.jpg GRAPHIC 28919
8 nc10024793x1_img007.jpg GRAPHIC 2825
9 nc10024793x1_img008.jpg GRAPHIC 12052
10 nc10024793x1_img009.jpg GRAPHIC 13473
11 nc10024793x1_img010.jpg GRAPHIC 5257
12 nc10024793x1_img011.jpg GRAPHIC 1810
13 nc10024793x1_img012.jpg GRAPHIC 2318
14 nc10024793x1_img013.jpg GRAPHIC 1708
15 nc10024793x1_img014.jpg GRAPHIC 14664
16 nc10024793x1_img015.jpg GRAPHIC 9747
17 nc10024793x1_img016.jpg GRAPHIC 3471
18 nc10024793x1_img017.jpg GRAPHIC 2668
19 nc10024793x1_img018.jpg GRAPHIC 3042
20 nc10024793x1_img019.jpg GRAPHIC 21521
21 nc10024793x1_img020.jpg GRAPHIC 16547
22 nc10024793x1_img021.jpg GRAPHIC 25700
23 nc10024793x1_img022.jpg GRAPHIC 31036
24 nc10024793x1_img023.jpg GRAPHIC 26516
25 nc10024793x1_img024.jpg GRAPHIC 25868
26 nc10024793x1_img025.jpg GRAPHIC 14386
27 nc10024793x1_img026.jpg GRAPHIC 35364
28 nc10024793x1_img027.jpg GRAPHIC 40510
29 nc10024793x1_img028.jpg GRAPHIC 36195
30 nc10024793x1_img029.jpg GRAPHIC 35723
31 nc10024793x1_pc01.jpg GRAPHIC 929678
32 nc10024793x1_pc02.jpg GRAPHIC 821073
  Complete submission text file 0001140361-21-021742.txt   3827913
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-11460 | Film No.: 211031571
SIC: 2834 Pharmaceutical Preparations